Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC), defined as lack of estrogen and progesterone receptors in the absence of protein overexpression/gene amplification of human epidermal growth factor receptor 2, is still a clinical challenge despite progress in breast cancer care. (1)H magnetic resonance spectros...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Iorio, Egidio, Caramujo, Maria José, Cecchetti, Serena, Spadaro, Francesca, Carpinelli, Giulia, Canese, Rossella, Podo, Franca
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5043614/
https://ncbi.nlm.nih.gov/pubmed/27747192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00205
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars